{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:01:36Z","timestamp":1773939696812,"version":"3.50.1"},"reference-count":50,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"unspecified","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-CTGIIT18may-0003"],"award-info":[{"award-number":["MOH-CTGIIT18may-0003"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/Fellowship\/0051\/2017"],"award-info":[{"award-number":["NMRC\/Fellowship\/0051\/2017"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K006924\/1"],"award-info":[{"award-number":["MR\/K006924\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,4,15]]},"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Ventilator-associated pneumonia (VAP) is the most common nosocomial infection in intensive care units (ICUs). Using short-course antibiotics to treat VAP caused by Gram-negative non-fermenting bacteria has been reported to be associated with excess pneumonia recurrences. The \u201cREducinG Antibiotic tReatment Duration for Ventilator-Associated Pneumonia\u201d (REGARD-VAP) trial aims to provide evidence for using a set of reproducible clinical criteria to shorten antibiotic duration for individualised treatment duration of VAP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a randomised controlled hierarchical non-inferiority\u2013superiority trial being conducted in ICUs across Nepal, Thailand and Singapore. The primary outcome is a composite endpoint of death and pneumonia recurrence at day 60. Secondary outcomes include ventilator-associated events, multidrug-resistant organism infection or colonisation, total duration of antibiotic exposure, mechanical ventilation and hospitalisation. Adult patients who satisfy the US Centers for Disease Control and Prevention National Healthcare Safety Network VAP diagnostic criteria are enrolled. Participants are assessed daily until fever subsides for &gt;48\u2009hours and have stable blood pressure, then randomised to a short duration treatment strategy or a standard-of-care duration arm. Antibiotics may be stopped as early as day 3 if respiratory cultures are negative, and day 5 if respiratory cultures are positive in the short-course arm. Participants receiving standard-of-care will receive antibiotics for at least 8\u2009days. Study participants are followed for 60 days after enrolment. An estimated 460 patients will be required to achieve 80% power to determine non-inferiority with a margin of 12%. All outcomes are compared by absolute risk differences. The conclusion of non-inferiority, and subsequently superiority, will be based on unadjusted and adjusted analyses in both the intention-to-treat and per-protocol populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study has received approvals from the Oxford Tropical Research Ethics Committee and the respective study sites. Results will be disseminated to patients, their caregivers, physicians, the funders, the critical care societies and other researchers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03382548\">NCT03382548<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-050105","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T13:22:29Z","timestamp":1620912149000},"page":"e050105","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct03382548","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0216-9550","authenticated-orcid":false,"given":"Yin","family":"Mo","sequence":"first","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"},{"name":"Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand"},{"name":"University Medicine Cluster, National University Hospital, Singapore"},{"name":"Department of Medicine, National University of Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy Eoin","family":"West","sequence":"additional","affiliation":[{"name":"International Respiratory and Severe Illness Center, University of Washington, Seattle, Washington, USA"},{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"MacLaren","sequence":"additional","affiliation":[{"name":"National University Heart Centre, National University Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchart","family":"Booraphun","sequence":"additional","affiliation":[{"name":"Medical Department, Sunpasithiprasong Hospital, Ubon Ratchathani, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew Yunkai","family":"Li","sequence":"additional","affiliation":[{"name":"University Medicine Cluster, National University Hospital, Singapore"},{"name":"Department of Medicine, National University of Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyan","family":"Kayastha","sequence":"additional","affiliation":[{"name":"Patan Hospital, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yie Hui","family":"Lau","sequence":"additional","affiliation":[{"name":"Anaesthesiology, Intensive Care and Pain Medicine, Tan Tock Seng Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin Tze","family":"Chew","sequence":"additional","affiliation":[{"name":"Anaesthesiology, Intensive Care and Pain Medicine, Tan Tock Seng Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ploenchan","family":"Chetchotisakd","sequence":"additional","affiliation":[{"name":"Department of Medicine,Srinagarind Hospital, Faculty of Medicine and Research and Diagnostic Center for Emerging Infectious Diseases (RCEID), Khon Kaen University, Khon Kaen, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Anantharajah","family":"Tambyah","sequence":"additional","affiliation":[{"name":"University Medicine Cluster, National University Hospital, Singapore"},{"name":"Department of Medicine, National University of Singapore, Singapore"},{"name":"Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7240-5320","authenticated-orcid":false,"given":"Direk","family":"Limmathurotsakul","sequence":"additional","affiliation":[{"name":"Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Cooper","sequence":"additional","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"},{"name":"Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"key":"2025121220503536000_11.5.e050105.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1754"},{"key":"2025121220503536000_11.5.e050105.2","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases Society of America and the American thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis [Internet]"},{"key":"2025121220503536000_11.5.e050105.3","first-page":"508","article-title":"Hospital acquired pneumonia in the medical intensive care unit--a prospective study","volume":"40","author":"Stebbings","year":"1999","journal-title":"Singapore Med J"},{"key":"2025121220503536000_11.5.e050105.4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijid.2008.02.010","article-title":"Ventilator-Associated pneumonia in adults in developing countries: a systematic review","volume":"12","author":"Arabi","year":"2008","journal-title":"Int J Infect Dis"},{"key":"2025121220503536000_11.5.e050105.5","doi-asserted-by":"publisher","DOI":"10.1136\/thx.54.10.867"},{"key":"2025121220503536000_11.5.e050105.6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0022-5223(19)40261-4","article-title":"Pulmonary pathology in acute respiratory insufficiency: lung biopsy as a diagnostic tool","volume":"71","author":"Hill","year":"1976","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025121220503536000_11.5.e050105.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.19.2588"},{"key":"2025121220503536000_11.5.e050105.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041290"},{"key":"2025121220503536000_11.5.e050105.9","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.2.9909095"},{"key":"2025121220503536000_11.5.e050105.10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.5.1791"},{"key":"2025121220503536000_11.5.e050105.11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.2.533"},{"key":"2025121220503536000_11.5.e050105.12","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318287f713"},{"key":"2025121220503536000_11.5.e050105.13","doi-asserted-by":"publisher","DOI":"10.1086\/653053"},{"key":"2025121220503536000_11.5.e050105.14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq360"},{"key":"2025121220503536000_11.5.e050105.15","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.JJID.2014.282"},{"key":"2025121220503536000_11.5.e050105.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586"},{"key":"2025121220503536000_11.5.e050105.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.87802"},{"key":"2025121220503536000_11.5.e050105.18","unstructured":"U.S Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) . Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event, 2018. Available: https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/6pscvapcurrent.pdf"},{"key":"2025121220503536000_11.5.e050105.19","doi-asserted-by":"publisher","DOI":"10.1136\/thx.54.10.867"},{"key":"2025121220503536000_11.5.e050105.20","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31819def97"},{"key":"2025121220503536000_11.5.e050105.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052904"},{"key":"2025121220503536000_11.5.e050105.22","first-page":"CD006482","article-title":"Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia","volume":"10","author":"Berton","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121220503536000_11.5.e050105.23","unstructured":"European Society of Clinical Microbiology and Infectious Diseases . The European Committee on antimicrobial susceptibility testing. routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST. version 8.0, 2018. Available: http:\/\/www.eucast.org"},{"key":"2025121220503536000_11.5.e050105.24","unstructured":"CLSI . M100: antimicrobial susceptibility testing standards, 2019. Available: https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m100\/"},{"key":"2025121220503536000_11.5.e050105.25","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, buckmans . Non-Inferiority clinical trials to establish effectiveness guidance for industry, 2016. Available: http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm"},{"key":"2025121220503536000_11.5.e050105.26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.12688\/wellcomeopenres.15636.1","article-title":"Statistical considerations in the design and analysis of non-inferiority trials with binary endpoints in the presence of non-adherence: a simulation study","volume":"4","author":"Mo","year":"2019","journal-title":"Wellcome Open Res"},{"key":"2025121220503536000_11.5.e050105.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2215"},{"key":"2025121220503536000_11.5.e050105.28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201105-0867OC"},{"key":"2025121220503536000_11.5.e050105.29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i189"},{"key":"2025121220503536000_11.5.e050105.30","unstructured":"Hern\u00e1n M , Robins J . Causal inference: what if. Boca Raton: Chapman & Hall\/CRC, 2020. https:\/\/www.hsph.harvard.edu\/miguel-hernan\/causal-inference-book\/"},{"key":"2025121220503536000_11.5.e050105.31","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2244"},{"key":"2025121220503536000_11.5.e050105.32","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000059313.31477.2C"},{"key":"2025121220503536000_11.5.e050105.33","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000249826.81273.E4"},{"key":"2025121220503536000_11.5.e050105.34","doi-asserted-by":"publisher","DOI":"10.1086\/496923"},{"key":"2025121220503536000_11.5.e050105.35","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/01.TA.0000057229.70607.F2","article-title":"Does bronchoalveolar lavage enhance our ability to treat ventilator-associated pneumonia in a trauma-burn intensive care unit?","volume":"54","author":"Wahl","year":"2003","journal-title":"J Trauma"},{"key":"2025121220503536000_11.5.e050105.36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00000542-200602000-00006","article-title":"Ventilator-Associated pneumonia leading to acute lung injury after trauma: importance of Haemophilus influenzae","volume":"104","author":"St\u00e9phan","year":"2006","journal-title":"Anesthesiology"},{"key":"2025121220503536000_11.5.e050105.37","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.5.1618"},{"key":"2025121220503536000_11.5.e050105.38","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200406-746OC"},{"key":"2025121220503536000_11.5.e050105.39","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ095"},{"key":"2025121220503536000_11.5.e050105.40","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0b013e31816f1f7c"},{"key":"2025121220503536000_11.5.e050105.41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.19.2588"},{"key":"2025121220503536000_11.5.e050105.42","unstructured":"Center for Biologics Evaluation and Research (CBER) C for DE and R (CDER) . Guidance for industry non-inferiority clinical trials, 2010. Available: http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm"},{"key":"2025121220503536000_11.5.e050105.43","unstructured":"Rothmann MD , Wiens BL , Chan ISF . Design and analysis of non-inferiority trials. Amsterdam: Chapman and Hall\/CRC, 2011: 454. https:\/\/www.crcpress.com\/Design-and-Analysis-of-Non-Inferiority-Trials\/Rothmann-Wiens-Chan\/p\/book\/9781584888048"},{"key":"2025121220503536000_11.5.e050105.44","doi-asserted-by":"publisher","DOI":"10.2307\/2531438"},{"key":"2025121220503536000_11.5.e050105.45","unstructured":"ELSEVIER . MACRO electronic data capture, 2019. Available: https:\/\/www.elsevier.com\/en-gb\/solutions\/macro"},{"key":"2025121220503536000_11.5.e050105.46","doi-asserted-by":"crossref","unstructured":"Jennison C , Turnbull BW . Group sequential methods with applications to clinical trials. London: Chapman & Hall\/CRC, 2000: 390.","DOI":"10.1201\/9781584888581"},{"key":"2025121220503536000_11.5.e050105.47","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/64.2.191"},{"key":"2025121220503536000_11.5.e050105.48","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00053209"},{"key":"2025121220503536000_11.5.e050105.49","article-title":"Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia","volume":"10","author":"Berton","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121220503536000_11.5.e050105.50","first-page":"1","article-title":"CONSORT 2010 statement : extension to randomised pilot and feasibility trials The Consolidated Standards of Reporting Trials (CONSORT) statement reporting of randomised controlled an extension to that statement for","volume":"2016","author":"Eldridge","year":"2010","journal-title":"BMJ Br Med J"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-050105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T04:50:45Z","timestamp":1765601445000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-050105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5,13]]},"published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10.1136\/bmjopen-2021-050105"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-050105","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]}}}